While creating your strategic vision and developing your plan to bring your ATMP to the patient, you have certainly realized that the process is long and that it will cost a lot of money. A return for all those investments, both in time and money, is desirable. This is only possible if your product has sufficient exclusivity. An exclusivity that protects your development, your clinical data and ultimately your product.